Sudo Biosciences, Inc.

Amendment
CIK: 0001860521·Other Technology·DELAWARE·Filed: Feb 15, 2024
Total Offering

$161,763,255

Amount Sold

$63,596,587

Investors

15

First Sale

Dec 15, 2023

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2020
Non-Accredited Investors
No

Related Persons

NameRole
Scott Byrd
Related Person
Daniel Estes
Related Person
David Johnson
Related Person
Edd Fleming
Related Person
Shinichiro Fuse
Related Person
Chris Gagliardi
Related Person

Company

Sudo Biosciences, Inc.

10401 N. MERIDIAN STREET

CARMEL, IN, 46290

317-564-8990

SEC Filing

0001860521-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Sudo Biosciences, Inc. Form D Filing — $161,763,255 | FilingFlow